Blinatumomab improves event-free survival in children with high-risk B-cell ALL

1 month ago 6
Blinatumomab is associated with importantly higher event-free endurance among children with recently diagnosed high-risk B-cell acute lymphoblastic leukemia (ALL), according to a survey published successful the Sept. 17 contented of the New England Journal of Medicine.
Read Entire Article